top
Search terms
Results 1 - 9 of 9 - ordered by :
Eurointervention

EuroIntervention Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot GENOUS trial EMO GVM ...

Date : 30/11/2011 Item size : 35913 bytes
Eurointervention

Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA Bioresorbable scaffolds represent an exciting milestone in the development of coronary stent technology with the ...

Date : 18/09/2016 Item size : 33406 bytes
Eurointervention

National University Heart Centre, Singapore, Singapore Aims: The aim of this study is to compare the clinical outcomes after transcatheter aortic valve implantation with the Edwards SAPIEN/SAPIEN XT ...

Date : 28/09/2014 Item size : 32902 bytes
Eurointervention

National University Heart Centre, Singapore, Singapore Aims: The aim of this study was to assess the contribution of mitral regurgitation to clinical outcomes after transcatheter aortic valve ...

Date : 28/09/2014 Item size : 32474 bytes
Eurointervention

EuroIntervention Clinical outcomes of Asian patients with low to intermediate risk undergoing transcatheter aortic valve implantation National University Heart Centre, Singapore, Singapore Aims: ...

Date : 28/09/2014 Item size : 32121 bytes
Eurointervention

Shonan Kamakura General Hospital, Kamakura, Japan Aims: Transcatheter aortic valve replacement (TAVR) has been established as alternative treatment for inoperable or high-risk patients with ...

Date : 14/09/2015 Item size : 32647 bytes
Eurointervention

Intravascular Imaging Core Laboratory, Cardiovascular Research Foundation, New York, United States Aims: Following the REMEDEE randomised trial (non-inferiority to Taxus stent) this is the first ...

Date : 21/05/2013 Item size : 35124 bytes
Eurointervention

EuroIntervention Twelve-month results of the REMEDEE trial: a randomised comparison of a sirolimus-eluting CD 34 antibody-coated stent versus a paclitaxel-eluting stent in patients with de-novo ...

Date : 15/05/2012 Item size : 34556 bytes
Eurointervention

By multivariate analysis, valve implant depth quartile was the strongest independent predictor of 30-day pacemaker implantation (hazard ratio 1.81; 95% confidence interval 1.18-2.77; p0.01), followed ...

Date : 21/05/2013 Item size : 32991 bytes